InvestorsHub Logo
Followers 56
Posts 8436
Boards Moderated 0
Alias Born 05/14/2015

Re: parkourstar post# 28884

Tuesday, 06/19/2018 9:30:06 AM

Tuesday, June 19, 2018 9:30:06 AM

Post# of 32013
It's not difficult. It actually is very simple. But like anything else, there is a learning curve especially when one is used to injection, which itself also has a learning curve.

Diabetes is a very difficult disease to manage and why many don't.

The failure of Afrezza, so far, isn't the drug itself. It has been a combo of management and a billion dollar liquid insulin industry trying to keep a wonder drug from ruining its monopoly.

If Afrezza was so difficult to use, why then are people ditching their pumps in favor of it?

At least be intellectually honest about what the issues surrounding the drug are.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MNKD News